Ticker: AIM

Company: HEMISPHERX BIOPHARMA INC

Person: Thomas K Equels, director, officer

Transaction date: April 21, 2025

Reporting date: April 23, 2025

Average share price: 0.0254

Bought 1968504.0 shares for 50000.0